Altos Labs

Altos Labs is a biotechnology company dedicated to cellular rejuvenation programming aimed at restoring cell health and resilience. The organization seeks to develop innovative approaches to medicine that can reverse diseases, injuries, and disabilities. By uniting a community of prominent scientists, clinicians, and industry leaders, Altos Labs fosters collaboration across its operations in the San Francisco Bay Area, San Diego, and Cambridge, UK, while also engaging in significant partnerships in Japan. Through its research and initiatives, the company aspires to transform the landscape of medical treatment.

Hal Barron MD

Co-Founder, CEO and Co-Chairman

Richard Klausner MD

Co-Founder, Chief Scientist and Co-Chairman

1 past transactions

Dorian Therapeutics

Dorian Therapeutics develops therapeutics and technologies aimed at addressing aging-related health challenges. The company focuses on rejuvenating cells and tissues through novel small-molecule therapies and tools for cellular therapies, enabling medical practitioners to treat age-related conditions and enhance the effectiveness of adoptive immunotherapy. Its work spans diabetes, neurodegenerative diseases such as Alzheimer's, arthritis, sarcopenia, osteoarthritis, and osteoporosis, among others. By combining cellular and immunotherapy capabilities with targeted rejuvenation strategies, Dorian Therapeutics seeks to intervene in the biology of aging to improve patient outcomes and expand treatment options for age-associated diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.